medigraphic.com
ISSN 1405-1710 (Print)

2005, Number 2

<< Back Next >>

Rev Cent Dermatol Pascua 2005; 14 (2)

Psoriactic arthritis: How to identify it

Torres-González S, Aquino RA

Language: Spanish
References: 32
Page: 62-70
PDF size: 116.47 Kb.


ABSTRACT

Psoriatic arthritis (PsA) is defined as an inflammatory arthropathy that is pronounced in patients with psoriasis and it is characterized by absence of rheumatoid factor. A 25% of these patients have work incapacity, while a 10%, absolute incapacity. At the present time it is had treatments able to mitigate the symptoms, but not only to take part in the inflammatory processes of the joints and other manifestations so that the disease does not progress. On early diagnosis of psoriatic arthritis provides the opportunity with opportune intervention to improve the function, quality of life and mainly the slow progression of the disease. Since the dermatologist often is in contact with the enemy with carrying patients of psoriasis before the beginning of the manifestations you will articulate has the opportunity to diagnose it in early stages, and to suggest the initial therapy already has drug and biological treatments that improve the quality of life of our patients, to sensitize to use them early. A revision is made on how distinguishing it of other arthropathies and what drugs have demonstrated effectiveness.


REFERENCES

  1. La mayoría de casos de espondiloartritis no se diagnostican antes de los cinco años. I Simposio de Espondiloartritis, de la Sociedad Española de Reumatología (SER). 22 feb. 05, ceoma. Confederación Española de Organizaciones de Mayores.

  2. Nyfors A, Lemholt K. Psoriasis in children. Br J Dermatol 1975; 92: 437-442.

  3. Torre AJC. Manual SER de las enf. reumáticas, 4ª Ed. Sociedad Española de Reumatología, Panamericana. 2004; 49: 274-279.

  4. Artritis psoriásica, Instituto Ferran de Reumatología, S.L. Última Modificación 2005.

  5. Medina QLF. Artritis psoriásica: ¿Una artropatía seronegativa? Universidad del Valle Cali.

  6. Galadari, Fuchs, Lebwohl. Newly available treatments for psoriatic arthritis and their impact on skin psoriasis. The International Journal of Dermatology 2003; 42: 231-237.

  7. Yamamoto, Yokoseki, Nishioka. Clinical analysis of 21 patients with psoriasis arthropathy. The Journal of Dermatology 2005; 32: 84-90.

  8. Magliocco, Gottlieb. Etarnecept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases. J Am Acad Dermatol 2004; 51: 580.

  9. Michet CJ. Update on psoriatic arthritis. The International Journal of Dermatology 2004; 43: 479.

  10. Berman A, Reboredo G, Spindler A et al. Rheumatic manifestations in populations at risk for HIV infection. J. Rheumatol 1991; 18: 1564-1567.

  11. Berman A, Spindler A, Lucero E. Manifestaciones reumáticas asociadas a la infección por el virus de la inmunodeficiencia humana. Avances en medicina. Sociedad Argentina de Medicina: 1999: 97-105.

  12. Mease, Goffe. Diagnosis and treatment of psoriatic arthritis. J Am Acad Dermatol 2005; 52: 1-19.

  13. Buskila D, Langevitz P, Gladdman DD et al. Patients with rheumatoid arthritis are more tender than those with psoriatic arthritis. J Reumatol 1992; 19: 1115.

  14. Olsen C. Stein M. New drugs for rheumatoid arthritis. NEJM 2004; 350: 2167.

  15. Franklin FN. 2001. La artritis psoriásica: Recursos en la red de la artritis y otras enfermedades reumáticas pediátricas.

  16. Larroudé M, Capuccio A, Bovea G y cols. La columna cervical en artritis psoriásica. Hospital Francés, Buenos Aires.

  17. Burstein ZA. Psoriasis, afección dermatológica frecuente: conducta terapéutica. Diagnóstico 2004; 43(4).

  18. Michet CJ. Update on psoriatic arthritis. The International Journal of Dermatology 2004; 43: 479.

  19. Prodanowich, Fangchao, Taylor et al. Metotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2004; 52: 262.

  20. Magliocco, Gottlieb. Etarnecept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: Report of 3 cases. J Am Acad Dermatol 2004; 51: 580.

  21. Hsin-Su Yu. Psoriatic patients with arthropathy show significant expression of free HLA class I heavy chains on circulating monocytes: a potential role in the pathogenesis of psoriatic arthropathy. British Journal of Dermatology 2004; 151: 24-31.

  22. Bennett, Barker, Kirham. Successful treatment of severe psoriatic arthritis with adalimumab. British Journal of Dermatology 2004; 151: 492.

  23. Verazaluce, Morales. Arthritis Psoriásica. Rev Cent Dermatol Pascua 1998; 7: 155.

  24. Berman A, Spindler A, Lucero E. Manifestaciones reumáticas asociadas a la infección por el virus de la inmunodeficiencia humana. Avances en medicina. Sociedad Argentina de Medicina: 1999: 97-105.

  25. ¿Qué es artritis psoriásica? Sociedad Española de Reumatología 2004: 91-96.

  26. Ortiz-Santamaría V. Manifestaciones reumatológicas en pacientes VIH+. Unidad de Reumatología/Servicio de Medicina Interna, Hospital General de Granollers, Barcelona, Fuente: ttmed.com

  27. Schön MP, Boehncke WH. “Psoriasis”. NEMJ 2005; 352: 1899.

  28. Calamia K. Agentes AntiTNF y otras patologías autoinmunes. Departamento de Reumatología, Mayo Clinic Jacksonville, Florida, Estados Unidos. Medwave. Año 3, No. 8, Edición Septiembre 2003.

  29. Heydendael, Spuls, Opmeer C et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. NEJM 2003; 349: 658.

  30. Jones G, Crotty M, Brooks P. Intervenciones para la artritis psoriásica, La Cochrane Library plus 2005; núm 2.

  31. Fry L. An atlas of Psoriasis. New Jersey, Parthenon Publishing Group, 1992.

  32. Berman A, Espinoza LR, Díaz JD et al. Rheumatic manifestations of human immunodeficiency virus infection. Am J Med 1988; 85: 59-64.




2020     |     www.medigraphic.com